Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_assertion description "[With the established roles of IFN? and TLRs in atherosclerotic pathology, the STAT1-dependent signal integration between IFN? and TLR in ECs and VSMCs in response to exogenous and endogenous atherogenic ligands could result in amplification of pro-inflammatory responses in the damaged vessel and be a novel mechanism involved in the initiation and progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_assertion evidence source_evidence_literature NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_assertion SIO_000772 21346151 NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_assertion wasDerivedFrom befree-20140225 NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_assertion wasGeneratedBy ECO_0000203 NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP854531.RABJsqjqpBmFPy63nN_C4sXzsCLHMrYc2J2GxvLWtsQVg130_provenance.